Manatt Health January 31, 2024
Dylan Carson, Sophie Assadnia

Editor’s Note: The article below is the second in our three-part series, Federal Antitrust Enforcement in Health Care: 2023 Year in Review. (Click here to read part 1.) The series is based on our recent webinar, 2023 Health Care Enforcement Trends: Spotlight on Consumer Protection, Antitrust and Fraud. Click here to view the free webinar on demand.

Merger challenges in pharmaceuticals, medtech and devices received a lot of attention and resources at the Federal Trade Commission (FTC) and State Attorneys General in 2023. Success in several high profile enforcement actions was in many ways a preview of coming attractions in the antitrust arena, as enforcers focus on industry-changing deals and make an effort to address what they perceive as historical...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Govt Agencies, Health System / Hospital, Medical Devices, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Provider, Trends
Walgreens to go private in $10B deal
Healthcare & Life Sciences Private Equity Deal Tracker: Sycamore Partners to Acquire Walgreens
Sun Pharma buys Checkpoint and its new cancer drug
Monogram Health, Memorial Hermann Launch Joint Venture
Sun Pharma Acquires Checkpoint Therapeutics for $355 Million

Share This Article